Skip to Content

Imfinzi Prices, Coupons and Patient Assistance Programs

Imfinzi (durvalumab) is a member of the Anti-PD-1 monoclonal antibodies drug class and is commonly used for Non-Small Cell Lung Cancer and Urothelial Carcinoma.

Imfinzi Prices

This Imfinzi price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Imfinzi intravenous solution (50 mg/mL) is around $886 for a supply of 2.4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Solution

50 mg/mL Imfinzi intravenous solution
from $886.26 for 2.4 milliliters
Quantity Per unit Price
2.4 milliliters $369.28 $886.26
10 milliliters $366.72 $3,667.18

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Imfinzi Coupons and Rebates

Imfinzi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Imfinzi Access 360 Patient Savings Program: Qualified patients may pay no more than $0 per month with savings of up to $26,000 per year; for additional information contact the program at 844-275-2360.

Applies to:Imfinzi
Number of uses:One per person until program expires

Patient Assistance Programs for Imfinzi

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: AZ&Me Prescription Savings Program for people without insurance

Elligibility requirements:

  1. Must have no prescription coverage
  2. Varies
  3. Not specified
  4. The patient must also be a US resident, green card or work visa holder.
  5. People who are in Medicare and may be eligible for the Limited Income Subsidy can apply. However, if they are accepted into the LIS, they are no longer eligible for the AZ& Me Prescription Savings Program. Eligibility determined on a case-by-case basis.

Applicable drugs:

  • Imfinzi (durvalumab)

Provider: AZ&Me Prescription Savings Program for people with Medicare Part D

Elligibility requirements:

  1. May have Medicare Part D
  2. Varies
  3. Not specified
  4. The patient must also be a US resident, green card or work visa holder.
  5. Eligibility determined on a case-by-case basis. *Patients with Medicare Part B coverage may also be eligible. Contact program for details.

Applicable drugs:

  • Imfinzi (durvalumab)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Imfinzi (durvalumab)

Provider: Access 360

Elligibility requirements:

  1. Determined case by case
  2. Varies. *See below for details
  3. Not specified
  4. The patient must also be a US resident, green card or work visa holder.
  5. Access 360

Applicable drugs:

  • Imfinzi (durvalumab)
Hide